Jul 30, 2025 8:00 am EDT Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences
Jun 26, 2025 5:05 pm EDT Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting Results
May 5, 2025 5:05 pm EDT Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company
Apr 28, 2025 4:05 pm EDT Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
Mar 13, 2025 8:30 am EDT Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial
